The abnormally high level of circRNF220 was suggested to be an adverse and independent prognostic marker for AML reoccurrence, its knockdown specifically inhibited AML proliferation and facilitated its apoptosis via interacting with miR‐30a to increase MYSM1 and IER2 expression.29 The gene discussed is MYSM1; the disease is acute myeloid leukemia.